Promoter holding
64.27%
AB
Abbott - Due diligence report
A 360° intelligence report on Abbott: trust score, financial health, credit view, compliance, directors, growth and distress signals - gener…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Abbott — 360° Intelligence Report
Generated from MCA filings & public records77/100
Trust Score
Low Risk
Abbott is assessed as Low Risk with a Trust Score of 77/100. Abbott is an active public limited indian non-government company incorporated in 1944, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.
Report generated on 21 Sep 2026 from the latest processed filings. Abbott India Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
77/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
72/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
85/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
90/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreCaution Indicated
40/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
85/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 90/100 Low Risk
- Liabilities ≈ 38% EBITDA - serviceable.
- No open charges - unencumbered balance sheet.
- Working-capital cover adequate.
- Profitable - internal accruals available.
Charges position: 0 open (-) · 0 satisfied (-).
Compliance Score: 72/100 Moderate
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Litigation present in 4 court forum(s).
- Delayed payments to MSME suppliers disclosed (244 disclosure(s)).
- 25 active GST registration(s).
Legal cases on record (4)
05
Director Intelligence
Stability score: 40/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| SRIDHAR VENKATESWARAN KADANGODE | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| MUNIR SHAIKH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| NEERAJ JAIN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Alison Elizabeth Davies | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SHALINI KALSI KAMATH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SANGEETA M SHETTY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| MAITHILEE KAIZAD MISTRY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SUDARSHAN KAILASH CHANDRA JAIN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| KARTIK RAJENDRAN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| KAIYOMARZ MINOO MARFATIA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| DARSHAN PRAVIN GADA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| VIVEK MOHAN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Maithilee Kaizad Mistry | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Sangeeta Mukesh Shetty | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| James Russell Wenner | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 15 directors on the board.
- DARSHAN PRAVIN GADA has DIN status "Deactivated due to non-filing of DIR-3 KYC".
- 2 director exit(s) in the last 3 years.
Director & KMP remuneration (FY 2024)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2025 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Abbott Capital India Limited
Subsidiaries
-
Group entities
-
Capital events
0 allotment(s) · 1 transfer(s)
Promoters hold a minority stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Abbott Capital India Limited | Holding Company | 74.00% |
Key managerial personnel: SRIDHAR VENKATESWARAN KADANGODE (CFO) · MAITHILEE KAIZAD MISTRY (CFO) · KARTIK RAJENDRAN (Managing Director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 85 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
Profit expanded 2.1x year-on-year.
Net margin improved to 24%.
Operating for 82+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
MSME payment delays disclosed - latest outstanding 3.30 cr.
4 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence79/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- No distress signals on file.
- Financial filings available for verification.
Banker assessment84/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- No existing security registered - first-charge position available.
- Compliance record supports lending.
Investor view83/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 3 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management churn warrants questions.
09
MCA Filings & Events Timeline
Latest 15 events25 Apr 2026
Director appointed
NEERAJ JAIN (Director)
23 Apr 2026
Director appointed
James Russell Wenner (Director)
01 Jan 2026
Director appointed
VIVEK MOHAN (Director)
18 Aug 2025
Director appointed
DARSHAN PRAVIN GADA (Director)
13 Aug 2025
Last AGM held
Annual general meeting
14 Jun 2025
Director appointed
KARTIK RAJENDRAN (Managing Director)
29 May 2025
Director appointed
Maithilee Kaizad Mistry (Cfo)
06 May 2025
Director appointed
MAITHILEE KAIZAD MISTRY (CFO)
31 Mar 2025
Latest balance sheet
Filed with ROC
07 Nov 2024
Director ceased
SRIDHAR VENKATESWARAN KADANGODE
13 Jun 2024
Director appointed
Alison Elizabeth Davies (Director)
01 Apr 2024
Director ceased
SWATI ROHAN DALAL
16 Sep 2023
Director appointed
Sangeeta Mukesh Shetty (Company Secretary)
14 Sep 2023
Director appointed
SANGEETA M SHETTY (Company Secretary)
08 Aug 2023
Director ceased
MAHADEO PURUSHOTTAM KARNIK
10
Key Observations
Auto-generated from the data aboveRevenue grew 0.86 over the last 4 financial year(s).
Net profit margin moved from 61% to 38%.
Net worth is positive.
15 active director(s) / partner(s); review board churn before relying on management continuity.
25 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a minority stake as per the FY 2025 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
| Company | CIN | Location |
|---|---|---|
| Alembic | L26100GJ1907PLC000033 | Baroda, Gujarat, India |
| Alembic Pharmaceuticals | L24230GJ2010PLC061123 | Vadodara, Gujarat, India |
| Supreme Petrochem | L23200MH1989PLC054633 | Mumbai, Maharashtra, India |
| Thermax | L29299PN1980PLC022787 | Pune, Maharashtra, India |
| Ipca Laboratories | L24239MH1949PLC007837 | Kandivali West, Maharashtra, India |
| Apitoria Pharma Private Limited | U24298TG2017PTC121342 | Hyderabad, Telangana, India |
| Nirma | U24240GJ1980PLC003670 | Ahmedabad, Gujarat, India |
| Maithri Laboratories Private Limited | U24239TG2002PTC038674 | Hyderabad, Telangana, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Abbott before audits and certifications: compliance score 72/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Abbott: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 90/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 85/100, margin trends, ownership structure and peer set for Abbott - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 77/100, distress signals and MSME payment-delay disclosures - know whether Abbott pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (4 case(s) on record), regulatory flags, charge documents trail and director networks for Abbott - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Abbott an active company?
Abbott has MCA status “Active” with a compliance score of 72/100 (Moderate).
Is Abbott financially healthy?
Abbott has a Financial Health Score of 85/100 (Low Risk) based on its filed financial statements.
Should I do business with Abbott?
Its overall Trust Score is 77/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Abbott?
The ultimate holding entity is Abbott Capital India Limited. 15 active director(s) are on record.
Does Abbott have loans or charges against its assets?
No charges are registered against this company - an unencumbered balance sheet.
Is Abbott up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 72/100 (Moderate).
Is it risky to lend to Abbott?
Its Credit Risk Score is 90/100 (Low Risk). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
